Letting post-marketing bridge the evidence gap: the case of orphan drugs.

MLA

Joppi, Roberta, et al. “Letting Post-Marketing Bridge the Evidence Gap: The Case of Orphan Drugs.” BMJ (Clinical Research Ed.), vol. 353, June 2016, p. i2978. EBSCOhost, https://doi.org/10.1136/bmj.i2978.

APA

Joppi, R., Gerardi, C., Bertele’, V., & Garattini, S. (2016). Letting post-marketing bridge the evidence gap: the case of orphan drugs. BMJ (Clinical Research Ed.), 353, i2978. https://doi.org/10.1136/bmj.i2978

Chicago

Joppi, Roberta, Chiara Gerardi, Vittorio Bertele’, and Silvio Garattini. 2016. “Letting Post-Marketing Bridge the Evidence Gap: The Case of Orphan Drugs.” BMJ (Clinical Research Ed.) 353 (June): i2978. doi:10.1136/bmj.i2978.